Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil.

Perazzo H, Jorge MJ, Silva JC, Avellar AM, Silva PS, Romero C, Veloso VG, Mujica-Mota R, Anderson R, Hyde C, Castro R

Open source

DOI
10.1186/s12876-017-0676-8
Published
2017 Nov 23
Container
BMC gastroenterology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12876-017-0676-8,
  title = {Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil.},
  author = {Perazzo H and Jorge MJ and Silva JC and Avellar AM and Silva PS and Romero C and Veloso VG and Mujica-Mota R and Anderson R and Hyde C and Castro R},
  year = {2017},
  journal = {BMC gastroenterology},
  doi = {10.1186/s12876-017-0676-8},
  url = {https://doi.org/10.1186/s12876-017-0676-8}
}

RIS

TY  - JOUR
TI  - Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil.
AU  - Perazzo H
AU  - Jorge MJ
AU  - Silva JC
AU  - Avellar AM
AU  - Silva PS
AU  - Romero C
AU  - Veloso VG
AU  - Mujica-Mota R
AU  - Anderson R
AU  - Hyde C
AU  - Castro R
PY  - 2017
JO  - BMC gastroenterology
DO  - 10.1186/s12876-017-0676-8
UR  - https://doi.org/10.1186/s12876-017-0676-8
ER  - 

APA

H, P., MJ, J., JC, S., AM, A., PS, S., C, R., VG, V., R, M., R, A., C, H., & R, C. (2017). Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil.. BMC gastroenterology. https://doi.org/10.1186/s12876-017-0676-8

Source records